Prognostic significance of combination of preoperative platelet count and neutrophil-lymphocyte ratio (COP-NLR) in patients with non-small cell lung cancer: Based on a large cohort study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Zhang, Hua ^a,b,c   Zhang, Lianmin ^a,b,c   Zhu, Kaikai ^a   Shi, Bowen ^a,b,c   Yin, Yuesong ^a,b,c   Zhu, Jinfang ^a,b,c   Yue, Dongsheng ^a,b,c   Zhang, Bin ^a,b,c   Wang, Changli ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c Tianjin Lung Cancer Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CELL RATIO; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; COMBINATION OF PLATELET COUNT AND NEUTROPHIL LYMPHOCYTE RATIO; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; NON SMALL CELL LUNG CANCER; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RISK BENEFIT ANALYSIS; SURVIVAL PREDICTION; THROMBOCYTE COUNT; BLOOD; CYTOLOGY; LUNG TUMOR; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84929095118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126496     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249. doi: 10.3322/caac.20006 PMID: 19474385
2. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867. PMID: 12490959
3. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545. PMID: 11229684
4. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60: 184-190. PMID: 10646872
5. McMillan DC (2013) The systemic inflammation-based Glasgow prognostic score: A decade of experience in patients with cancer. Cancer Treat Rev 39: 534-540. doi: 10.1016/j.ctrv.2012.08.003 PMID: 22995477
6. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. (2009) Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197: 466-472. doi: 10.1016/j.amjsurg.2007.12.057 PMID: 18639229
7. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T (2011) Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res 31: 2995-2998. PMID: 21868550
8. Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA (2014) Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer 110: 1930-1935. doi: 10.1038/bjc.2014.145 PMID: 24667648
9. Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, Tanaka M, et al. (2004) Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71: 170-173. PMID: 15031573
10. Maráz A, Furák J, Varga Z, Kahán Z, Tiszlavicz L, Hideghéty K (2013) Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Res 33: 1725-1729. PMID: 23564823
11. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2013) Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 109: 401-407. doi: 10.1038/bjc.2013.350 PMID: 23820256
12. Ishizuka M, Oyama Y, Abe A, Kubota K (2014) Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol 110: 935-941. doi: 10.1002/jso.23753 PMID: 25146385
13. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706-714. PMID: 17762336
14. Suzuki K, Kadota K, Sima CS, Nitadori J, Rusch VW, Travis WD, et al. (2013) Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor uz (IL-12R, K, IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.J Clin Oncol 31:490-498. doi: 10.1200/JCO.2012.45.2052 PMID: 23269987
15. Ruffini E, Asioli S, Filosso PL, Lyberis P, Bruna MC, Macrì L, et al. (2009) Clinical significance of tumorinfiltrating lymphocytes in lung neoplasms. Ann Thorac Surg 87:365-371. doi: 10.1016/j.athoracsur.2008.10.067 PMID: 19161739
16. Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, et al. (2011) Prognostic immune markers in non-small cell lung cancer.Clin Cancer Res 17:5247-5256. doi: 10.1158/1078-0432.CCR-10-2805 PMID: 21659461
17. de Gaetano G (2001) Historical overview of the role of platelets in hemostasis and thrombosis. Haematologica 86: 349-356. PMID: 11325638
18. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, et al. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964. PMID: 9528841
19. Senzel L, Gnatenko DV, Bahou WF (2009) The platelet proteome. Curr Opin Hematol 16: 329-333. doi: 10.1097/MOH.0b013e32832e9dc6 PMID: 19550320
20. Wakefield LM, Smith DM, Flanders KC, Sporn MB (1988) Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 263: 7646-7654. PMID: 3163692
21. Guo F, Parker Kerrigan BC, Yang D, Hu L, Sood AK, Sood AK, et al. (2014) Post-transcriptional regulatory network of epithelial-tomesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol 7: 19. doi: 10.1186/1756-8722-7-19 PMID: 24598126
22. Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC (2001) Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol Cell Biol 21: 6387-6394. PMID: 11533228
23. Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576-590. doi: 10.1016/j.ccr.2011.09.009 PMID: 22094253
24. Bambace NM, Holmes CE (2011) The platelet contribution to cancer progression. J Thromb Haemost 9: 237-249. doi: 10.1111/j.1538-7836.2010.04131.x PMID: 21040448
25. Guthrie GJ, Roxburgh CS, Horgan PG, McMillan DC (2013) Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev 39: 89-96. doi: 10.1016/j.ctrv.2012.07.003 PMID: 22858249
26. O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ (2010) The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 5: 2024-2036. PMID: 21155185
27. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6: 283-287. PMID: 15166496
28. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181-184. PMID: 16118772
29. Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C (2010) Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 34: 285-290. doi: 10.1007/s00268-009-0302-1 PMID: 19997918
30. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI (2010) Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 200: 197-203. doi: 10.1016/j.amjsurg.2009.08.041 PMID: 20122680
31. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, et al. (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19: 217-224. doi: 10.1245/s10434-011-1814-0 PMID: 21638095
32. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS (2002) D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121: 1262-1268. PMID: 11948062
33. De Buyzere M, Philippé J, Duprez D, Baele G, Clement DL (1993) Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 43: 91-94. PMID: 8342557
34. Yamashita H, Kitayama J, Kanno N, Yatomi Y, Nagawa H (2006) Hyper fibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6: 147. PMID: 16740157